š§¬ This Week in Gene & Cell Therapy: GVHD Breakthroughs, CAR-T Success, FDA Updates, and More
From a ground-breaking GVHD prevention study for mismatched unrelated donor transplants to the latest CAR-T therapy results, this weekās episode highlights pivotal advancements in gene and cell therapy. Whether you’re tracking the progress of gene therapies in blood cancer, ground-breaking FDA reviews, or major corporate developments, this episode delivers the must-know news shaping the future of medicine. š¬š”
š Highlights in this episode:
ā¤ļø NMDP and CIBMTR launch a pioneering GVHD prevention study for MMUD transplants
š§¬ Rocket Pharmaceuticals accelerates gene therapy pipeline with FDA RMAT designations
š Bluebird Bioās Skysona faces FDA restrictions amid rising blood cancer risks
š”ļø Sarepta Therapeutics resumes ELEVIDYS shipments for Duchenne after FDA review
š¬ Tenaya Therapeutics announces significant progress in HCM and ARVC gene therapy trials
šļø Neurotech Pharmaceuticals secures FDA approval for the first MacTel gene therapy
š§ Immuneel Therapeuticsā CAR-T therapy shows impressive long-term success in blood cancer treatment
šŖšŗ European Commission approves AGC Biologicsā CAR-T therapy for relapsed/refractory B-ALL
ā” FDA grants Priority Review for Liso-Cel in relapsed marginal zone lymphoma
š¬ Precision BioSciences advances PBGENE-HBV for chronic Hepatitis B with promising Phase 1 data
š§Ŗ Senti Bio reveals Phase 2 dose for SENTI-202 CAR-NK therapy with complete remissions
š« Allogene discontinues ALLO-647 after patient death in lymphoma trial linked to immune suppression
This isnāt just a news roundupāitās your essential look at the trailblazing research and innovations transforming gene and cell therapy today. šÆ
š¢ Stay Ahead in Gene and Cell Therapy Research!
ā Like, share, and subscribe for weekly updates on gene therapy, cell therapy, rare diseases, and biotech innovation
#GeneTherapy #CellTherapy #BiotechNews #GVHD #BloodCancer #CAR_T #GeneEditing #FDA #DuchenneMuscularDystrophy #ClinicalTrials #BiotechInnovation #LucidQuest #LQVentures